Used in research and therapeutic development targeting metabolic disorders, this antibody inhibits ANGPTL4 activity, leading to reduced plasma triglyceride levels by promoting lipoprotein lipase activation. It has potential application in treating hyperlipidemia and atherosclerosis. Studies also explore its role in cancer, as ANGPTL4 is involved in tumor progression and metastasis; blocking it may suppress tumor growth and angiogenesis. Additionally, it is employed as a detection and quantification tool in immunoassays for ANGPTL4 expression analysis in biological samples.